Structure determination of Fms and Kit kinases and their inhibtors for directed drug design [ 2007 - 2009 ]

Research Grant

Researchers: Neal Williams (Principal investigator)

Brief description Tyrosine kinases are a large and important family of enzymes that play a fundamental role in the control and communication between cells. When damaged or uncontrolled, these enzymes can contribute to the development of diseases such as cancer and immune related disorders. This proposal aims to develop therapeutics targeted at the tyrosine kinases using a combination of the Structure Biology expertise at Monash University and the drug discovery platform technologies of Cytopia Pty Ltd. Promising drug candidates already identified by Cytopia will be analysed at their site of action using X-ray crystallography. This information will enable a rational process of modification and improvement of the candidate drugs. The development of a range of therapeutics for Phase I clinical trials will be of enormous benefit to Australia�s medical industry and pubic health.

Funding Amount $AUD 373,250.00

Funding Scheme Early Career Fellowships

Notes Industry ECF